Frequently Asked Questions

Ausel’s Heliora test is the first rapid, non-invasive multi-cancer early detection (MCED). No needles, special equipment, or waiting for results. Simply collect a saliva sample, add the solution & shake. The tube will stay brown for a negative result or immediately turn gray for a positive result, giving a Yes/ No answer you can see & trust.

Heliora is clinically validated to detect breast & lung cancers, including early-stage cancers. We are actively testing its capabilities to detect additional cancer types through ongoing research. Current trials have shown the test’s ability to accurately detect 12 different cancer types, including: Pancreatic Colorectal Esophageal Liver Ovarian Uterine Testicular Prostate Melanoma Nasopharyngeal

Our test is built on over 15 years of research & development. It has undergone extensive clinical studies, demonstrating exceptional predictive accuracy for breast cancer & lung cancer.

Unlike traditional tests, Heliora is: Non-invasive: No blood draws, fecal collections, or biopsies Rapid: Results in minutes, not weeks Accessible: No specialists or lab required, making it affordable & available to more people

Heliora detects specific sugars in saliva that are linked to cancer metabolism. These sugars play a well-established role in cancer biology. Read more in our article on cancer detection using sugars & explore additional research here.

Cancer doesn’t wait—so neither are we. Stay updated on our international availability by signing up for our mailing list & following us on social media!

We are committed to making Heliora affordable. Pricing details will be announced closer to its release, & we aim to work with healthcare systems to improve access.

Ausel was founded with a mission to make early cancer detection simple, affordable & accessible. Learn more about our story & values on the Home page. If you have more questions, feel free to reach out to us in the contact section below. We're here to help!